公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)! YZ剂描述: 产品名称:Paricalcitol 产品别名:见爱必信官网 英文别名:Paricalcitol 靶点:VD/VDR CAS:131918-61-1 纯度:98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder) 描述:Paricalcitol is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. 溶解性: In Vitro: DMSO : 100 mg/mL (240.02 mM; Need ultrasonic) Ethanol : 12.5 mg/mL (30.00 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) Preparing Stock Solutions ConcentrationSolventMass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.4002 mL | 12.0008 mL | 24.0015 mL | 5 mM | 0.4800 mL | 2.4002 mL | 4.8003 mL | 10 mM | 0.2400 mL | 1.2001 mL | 2.4002 mL |
*请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存方式和期限。 In Vivo: 请根据您的实验动物和给YF式选择适当的溶解方案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的工作 液,建议您现用现配,当天使用;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分比是指该溶剂在您配制终溶液中的体积占比): 1. 请依序添加每种溶剂: 10% DMSO 90% corn oil Solubility: ≥ 2.5 mg/mL (6.00 mM); Clear solution
* 体外研究: Paricalcitol (3×10-8 M; HP + PC) produces a significant reduction in calcification relative to the observed in cells in HP medium. Paricalcitol causes a reduction in the levels of nuclear β-catenin to a level similar to that observed in control cells. 体内研究:Paricalcitol (3×10-8 M; HP + PC) produces a significant reduction in calcification relative to the observed in cells in HP medium. Paricalcitol causes a reduction in the levels of nuclear β-catenin to a level similar to that observed in control cells. 产品信息订购: 产品货号 | 产品名称 | 规格 | 价格 | 大包装及货期 | abs820544 | Paricalcitol | 1mg | 1980 | 立即咨询 | 产品更多信息请进入爱必信网站咨询 |